{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:02:48Z","timestamp":1759010568004},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/inf.0000000000000745","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T13:33:17Z","timestamp":1430919197000},"page":"831-838","source":"Crossref","is-referenced-by-count":16,"title":["Group A Streptococcal Carriage and Seroepidemiology in Children up to 10 Years of Age in Australia"],"prefix":"10.1097","volume":"34","author":[{"given":"Helen S.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Booy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shite","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin U.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid L.","family":"Scully","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-6-20210202","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.","volume":"45","author":"OLoughlin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5694\/j.1326-5377.2007.tb01054.x","article-title":"The epidemiology of invasive group A streptococcal disease in Victoria, Australia.","volume":"186","author":"OGrady","year":"2007","journal-title":"Med J Aust"},{"key":"R6-6-20210202","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/clinids\/21.5.1220","article-title":"Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone.","volume":"21","author":"Carapetis","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R7-6-20210202","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases.","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1440-1754.1995.tb00795.x","article-title":"An epidemic of acute post-streptococcal glomerulonephritis among aboriginal children.","volume":"31","author":"Streeton","year":"1995","journal-title":"J Paediatr Child Health"},{"key":"R9-6-20210202","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4269\/ajtmh.2011.11-0185","article-title":"Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature.","volume":"85","author":"Marshall","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1017\/S095026880700917X","article-title":"High burden of invasive beta-haemolytic streptococcal infections in Fiji.","volume":"136","author":"Steer","year":"2008","journal-title":"Epidemiol Infect"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"e73851","DOI":"10.1371\/journal.pone.0073851","article-title":"Extensive diversity of Streptococcus pyogenes in a remote human population reflects global-scale transmission rather than localised diversification.","volume":"8","author":"Towers","year":"2013","journal-title":"PLoS ONE"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00006454-199705000-00008","article-title":"Success of a scabies control program in an Australian aboriginal community.","volume":"16","author":"Carapetis","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R14-6-20210202","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/QCO.0b013e328332bbfe","article-title":"Group A streptococcal vaccines: facts versus fantasy.","volume":"22","author":"Steer","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R16-6-20210202","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine.","volume":"70","author":"Hu","year":"2002","journal-title":"Infect Immun"},{"issue":"Suppl 2","key":"R17-6-20210202","doi-asserted-by":"crossref","first-page":"B216","DOI":"10.1016\/j.vaccine.2012.09.045","article-title":"Group A streptococcal vaccines: paving a path for accelerated development.","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"R18-6-20210202","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.","volume":"9","author":"Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R22-6-20210202","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/j.vaccine.2010.05.046","article-title":"Diversity of emm sequence types in group A beta-haemolytic streptococci in two remote northern territory indigenous communities: implications for vaccine development.","volume":"28","author":"Richardson","year":"2010","journal-title":"Vaccine"},{"key":"R23-6-20210202","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/377700","article-title":"Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development.","volume":"188","author":"Shet","year":"2003","journal-title":"J Infect Dis"},{"key":"R25-6-20210202","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1128\/IAI.70.11.6409-6415.2002","article-title":"Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.","volume":"70","author":"Cheng","year":"2002","journal-title":"Infect Immun"},{"key":"R26-6-20210202","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4161\/hv.4.2.5261","article-title":"Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil.","volume":"4","author":"Smith","year":"2008","journal-title":"Hum Vaccin"},{"key":"R29-6-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00157398","article-title":"Asymptomatic pharyngeal carriage of beta-haemolytic streptococci and streptococcal pharyngitis among patients at an urban hospital in Croatia.","volume":"9","author":"Begovac","year":"1993","journal-title":"Eur J Epidemiol"},{"key":"R30-6-20210202","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10096-003-0972-9","article-title":"Group A Streptococcal serotypes isolated from healthy schoolchildren in Iran.","volume":"22","author":"Fazeli","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl","key":"R31-6-20210202","first-page":"144","article-title":"The burden of group A streptococcal pharyngitis in Melbourne families.","volume":"119","author":"Danchin","year":"2004","journal-title":"Indian J Med Res"},{"key":"R32-6-20210202","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/CVI.00354-12","article-title":"A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.","volume":"19","author":"Hawkins","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"R33-6-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/650167","article-title":"The human immune response to streptococcal extracellular antigens: clinical, diagnostic and potential pathogenetic implications.","volume":"50","author":"Johnson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R34-6-20210202","first-page":"569","article-title":"Prevalence of positive throat cultures for group A beta-hemolytic streptococci among school children in Istanbul.","volume":"39","author":"Gur","year":"2002","journal-title":"Indian Pediatrics"},{"key":"R35-6-20210202","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1086\/341409","article-title":"Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.","volume":"35","author":"OBrien","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R36-6-20210202","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1128\/JCM.43.4.1678-1683.2005","article-title":"Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002).","volume":"43","author":"Tyrrell","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R37-6-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2807\/esm.10.09.00563-en","article-title":"The epidemiology of severe Streptococcus pyogenes associated disease in Europe.","volume":"10","author":"Lamagni","year":"2005","journal-title":"Euro Surveill"},{"key":"R41-6-20210202","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:07:17Z","timestamp":1620954437000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201508000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000745","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}